Twist Bioscience Corporation (TWST) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

ladies and gentlemen thank you for standing by welcome to twist bioscience fiscal 2026 first quarter financial results conference call at this time all participants are in the listen only mode after the speaker's presentation there will be a question and answer session to ask a question during the session you will need to press star 1 1 on your telephone you will then hear an automated message advising your hand is raised To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would like now to turn the conference over to Angela Bidding, Senior Vice President of Corporate Affairs. Please go ahead. Thank you, Operator. Good morning, everyone. I would like to thank you for joining us for TWIST Biosciences conference call to review our fiscal 2026 first quarter financial results and business progress. We issued our financial results press release before the market, and it is available at our website at www.twistbioscience.com. With me on the call today are Dr. Emily LaProust, CEO and co-founder of Twist, Adam Loponis, CFO of Twist, and Dr. Patrick Finn, President and COO of Twist. Today, we will discuss our business progress, financial and operational performance, as well as growth opportunities. We will then open the call for questions. We ask that you limit your questions to only one and then re-queue as a courtesy to others on the call. This call is being recorded. The audio portion will be archived in the investor section of our website and will be available for two weeks. During today's presentation, we will make forward-looking statements within the meaning of the U.S. federal securities laws. Forward-looking statements generally relate to future events or future financial or operating performance. Our ...